Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Shares Outstanding (Weighted Average) (2019 - 2025)

IDEAYA Biosciences' Shares Outstanding (Weighted Average) history spans 6 years, with the latest figure at $88.5 million for Q2 2025.

  • For Q2 2025, Shares Outstanding (Weighted Average) rose 15.6% year-over-year to $88.5 million; the TTM value through Jun 2025 reached $88.5 million, up 15.6%, while the annual FY2022 figure was $41.4 million, 17.57% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q2 2025 was $88.5 million at IDEAYA Biosciences, roughly flat from $88.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $88.5 million in Q2 2025 and bottomed at $35.3 million in Q4 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $60.0 million (2023), against an average of $62.4 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) surged 55.28% in 2024 before it rose 15.6% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $35.3 million in 2021, then rose by 17.57% to $41.4 million in 2022, then skyrocketed by 44.77% to $60.0 million in 2023, then skyrocketed by 32.96% to $79.8 million in 2024, then increased by 10.9% to $88.5 million in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Shares Outstanding (Weighted Average) are $88.5 million (Q2 2025), $88.4 million (Q1 2025), and $79.8 million (Q3 2024).